Globe Newswire
Globe Newswire
More Globe Newswire
View Older Stories View Newer Stories-
Mangoceuticals Announces the Launch of “PeachesRx” - a Women's Telehealth Brand Focused on Personalized Wellness and GLP-1 Weight Loss Treatments
-
ChampionX Declares Quarterly Dividend
-
Koryx Copper Announces Multiple Higher-Grade Drill Results Over Wide Intercepts at the Haib Copper Project, Southern Namibia
-
Agios to Present at the TD Cowen 45th Annual Healthcare Conference on March 3, 2025
-
Skye Bioscience to Present at TD Cowen Health Care Conference
-
BigCommerce Announces Fourth Quarter and Fiscal Year 2024 Financial Results
-
Supremex Announces Q4 and Year-End 2024 Results
-
G2 Goldfields Expands Team and Appoints VP, Investor Relations and VP, Business Development - Guyana
-
Unicycive Therapeutics Announces the Publication of Preclinical Data on Synergies Between Oxylanthanum Carbonate and Tenapanor in American Society of Nephrology Journal Kidney360
-
Pool Corporation Reports Year End and Fourth Quarter 2024 Results; Provides 2025 Earnings Guidance
-
Kymera Therapeutics to Report Fourth Quarter and Full Year 2024 Financial Results on February 27
-
Abcourt Intersects a New Gold Mineralized Zone Grading 1.3 g/t Gold over 28.5 Metres, 1.8 km West to the January 2025 Drilling on the Flordin Property in the Lebel-sur-Quévillon Area
-
Lantronix PoE++ Switches Help Power the World’s Largest DC-Powered Warehouse
-
Mangoceuticals Announces the Launch of “PeachesRx” - a Women's Telehealth Brand Focused on Personalized Wellness and GLP-1 Weight Loss Treatments
-
Luckin Coffee Announces Fourth Quarter and Fiscal Year 2024 Financial Results
-
Aben Minerals Management to Examine Forrest Kerr Gold Project
-
EnviroGold Global Closes First Tranche of Non-Brokered Private Placement
-
Seer to Feature Proteomic Advancements in Cancer and RNA Therapy Research among other Findings at US HUPO 2025
-
Kaltura Announces Financial Results for Fourth Quarter and Full Year 2024
-
atai Life Sciences Announces Closing of Public Offering and Full Exercise of Option to Purchase Additional Common Shares
-
Lungpacer Medical Announces Positive Results from STIMULUS Trial: Diaphragm Neurostimulation Improves Hemodynamic Performance During Mechanical Ventilation
-
Society for Clinical Research Sites (SCRS) and Fortrea Partner to Advance Collaboration in Clinical Research
-
Enthusiast Gaming’s Pocket Gamer Connects Announces Major Global Expansion with Launch of Barcelona Conference, Shanghai Summit
-
Shenandoah Telecommunications Company Reports Fourth Quarter and Full Year 2024 Results
-
Aquestive Therapeutics to Report Fourth Quarter 2024 Financial Results and Recent Business Highlights on March 5 and Host Conference Call on March 6 at 8:00 a.m. ET
-
FactSet Schedules Second Quarter 2025 Earnings Call
-
Zealand Pharma convenes its Annual General Meeting 2025
-
Gauzy Bolsters Presence in South Korea as Part of a Strategic Collaboration with MABA Industrial, Bringing AI-Powered Smart-Vision® Advanced Driver Assistance System to Critical Asia-Pacific Market
-
Garrett Motion Delivers Strong 2024 Financial Performance, Issues 2025 Outlook
-
Alliance Witan PLC - Net Asset Value
-
SpringWorks Therapeutics Reports Fourth Quarter and Full Year 2024 Financial Results and Highlights Recent Business Updates
-
Aveanna Announces Fourth Quarter and Full Year 2024 Earnings Release Date and Conference Call
-
Freshpet, Inc. Reports Fourth Quarter and Full Year 2024 Financial Results
-
Comstock Fuels Expands RenFuel Partnership
-
FibroGen Announces the Sale of FibroGen China to AstraZeneca for Approximately $160 Million
-
Northgate Real Estate Group Named #1 Bankruptcy, Foreclosure, and Restructuring Brokerage Firm in NYC, and Top 3 Nationwide
-
RetinalGenix Technologies Breakthrough in Real-Time 24/7 Remote Ocular Monitoring
-
Donegal Group Inc. Announces Fourth Quarter and Full Year 2024 Results
-
BW Offshore: Invitation to Q4 2024 Presentation 27 February
-
Gofaizen & Sherle Launches Full-Cycle CASP Licensing Service in Lithuania, Poland and Spain
-
Gofaizen & Sherle Launches Full-Cycle CASP Licensing Service in Lithuania, Poland and Spain
-
Pepe Punch: Proudly Unveil Our Groundbreaking Deflationary Token Model
-
Form 8.3 - [ALLIANCE PHARMA PLC - 19 02 2025] - (CGWL)
-
Form 8.3 - [LEARNING TECHNOLOGIES GROUP PLC - 19 02 2025] - (CGWL)
-
4 Nations Face-Off: Canadian Pride Would Surge if Canada Beat the U.S. in Hockey Showdown
-
SINTX Technologies Sells Technology Assesment and Transfer Subsidiary to Focus on Medical Device Market
-
Form 8.3 - AXA INVESTMENT MANAGERS: Aviva plc
-
Form 8.3 - AXA INVESTMENT MANAGERS: PRS REIT plc
-
Cenovus Announces Fourth-Quarter and Full-Year 2024 Results
-
Targa Resources Corp. Reports Record Fourth Quarter and Full Year 2024 Financial Results, Provides Growth Outlook for 2025 and Announces Refinancing of Badlands Preferred Equity
